Tindamax (tinidazole) Wholesaler Order Entry Numbers

There are no therapeutic equivalents.

Wholesaler	NDC 0178-8500-20 20 count Tindamax^® 500 mg	NDC 0178-8500-60 60 count Tindamax^® 500 mg	NDC 0178-8250-40 40 count Tindamax^® 250 mg
AmerisourceBergen	4969911/ 580757	Please call (800) 531-3333	Please call (800) 531-3333
Bellco	211502	''	''
Burlington Drug Co.	060095	''	''
Cardinal Health, Inc	3921442	''	''
Dik Drug	996629	''	''
Frank W. Kerr	037499	''	''
H D Smith	1535673	''	''
King Drug	147579	''	''
Kinray, Inc.	820589	''	''
Louisiana Wholesale	067116	''	''
McKesson Corp	1814722	''	''
McQueary Bros. Drug Co.	969850	''	''
Miami-Luken	022103	''	''
Morris & Dickson Co.	700161	''	''
NC Mutual Drug Co.	429746	''	''
Smith Drug Co.	363978	''	''
Value Drug Co.	364505	''	''

For additional stocking information please contact Customer Service at (800) 531-3333.

Important Safety Information

WARNING: POTENTIAL RISK FOR CARCINOGENICITY

Carcinogenicity has been seen in mice and rats treated chronically with metronidazole, another nitroimidazole agent. Although such data have not been reported for tinidazole, the two drugs are structurally related and have similar biologic effects. Its use should be reserved for the conditions described in INDICATIONS AND USAGE.

Contraindications

Prior history of hypersensitivity to tinidazole or other nitroimidazole derivatives
First trimester of pregnancy
Nursing mothers, unless breast-feeding is interrupted during tinidazole therapy and for 3 days following the last dose

Warnings and Precautions

Seizures and neuropathy have been reported. Discontinue Tindamax if abnormal neurologic signs develop
Vaginal candidiasis may develop with Tindamax and require treatment with an antifungal agent
Use Tindamax with caution in patients with blood dyscrasias. Tindamax may produce transient leukopenia and neutropenia

Adverse Reactions

Most common adverse reactions for a single 2 g dose of tinidazole (incidence >1%) are metallic/bitter taste, nausea, weakness/fatigue/malaise, dyspepsia/cramps/epigastric discomfort, vomiting, anorexia, headache, dizziness and constipation. To report SUSPECTED ADVERSE REACTIONS, contact Mission Pharmacal Company at 1-800-298-1087 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

This material is intended to provide basic information. Patients should discuss all medical advice, diagnosis, and treatment with their healthcare provider.

Please see full Prescribing Information